相关实验视频
Updated: Jul 15, 2025

05:47
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
7.3K
在类似抑郁的状态下,失调的血清能神经元-星细胞信号传递
Candela González-Arias1,2, Andrea Sánchez-Ruiz1,2, Julio Esparza1
1Cajal Institute, CSIC, 28002, Madrid, Spain.
Molecular psychiatry
|September 29, 2023
概括
在暴露于压力影响情绪和认知的青少年小鼠中改变了天体细胞信号. 恢复这种信号治疗改善了类似抑郁症的行为,这表明了新的治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 神经精神病学是一种神经精神病学.
背景情况:
- 星球细胞对于大脑平衡和神经元功能至关重要.
- 在重大抑郁症 (MDD) 中观察到星细胞变化.
- 天体细胞 (Ca2+) 信号在MDD中的作用尚不清楚.
研究的目的:
- 为了研究星细胞Ca2+信号在抑郁症小鼠模型中的后果.
- 探索调节星体Ca2+信号在类似抑郁的状态中的潜在治疗价值.
主要方法:
- 利用皮质激素治疗的青少年小鼠 (Cort-mice) 来模拟压力诱导的类似抑郁的行为.
- 使用成像测量了中间前额叶皮质 (mPFC) 中的天体细胞Ca2+动态.
- 评估了血清素 (5-HT) 介导的信号传递和突触可塑性.
- 雇佣了Gq-DREADDS来操纵天体细胞的Ca2+信号传递.
主要成果:
- 科特小鼠在mPFC中表现出改变的休息和活动依赖的天体细胞Ca2+动态,与行为变化相关.
- 在Cort-小鼠的mPFC星体和神经元中观察到减少的5-HT介导的Ca2+信号传递和受损的5-HT驱动的突触可塑性.
- 降低天体细胞Ca2+信号的调节模仿了突触缺陷,同时用Gq-DREADDS增强它在Cort-mice中挽救了情绪和认知障碍.
结论:
- 星细胞Ca2+信号传递对于维持大脑电路平衡和行为至关重要.
- 功能障碍的天体细胞Ca2+信号传递有助于类似抑郁的状态.
- 调节天体细胞Ca2+信号是MDD的一个有前途的治疗策略.
相关概念视频
G-protein Coupled Receptors
120.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.1K
Neurotransmitters
997
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
997
Antidepressant Drugs: MAOIs and Other Agents
266
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
266
Excitatory and Inhibitory Effects of Neurotransmitters
10.1K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
10.1K
Depression: Overview
271
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
271
Depressive Disorders: Etiology
114
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
114

